Latest Trials

EudraCT Number: 2004-003816-47 Sponsor Protocol Number: Met-ADI-01 Start Date:
Sponsor Name: Pädiatrische Endokrinologie, Universitätsmedizin Berlin, Charité
Full Title: Clinical pilot study on the effect of Metformin in adipose children and adolescents with insulin-resistance Klinische Pilotstudie zur Untersuchung der Wirkung von Metformin bei adipösen Kindern un...
Medical condition: Insuline-resistance in adipose children and adolescents
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2010-021139-15 Sponsor Protocol Number: ESC-928-MOL-0000-I Start Date:
Sponsor Name: Technische Universität München Fakultät für Medizin
Full Title: Do Selective Radiation Dose Escalation and Tumor Hypoxia Status Impact the Locoregional Tumor Control after Radiochemotherapy of Head & Neck Tumors?
Medical condition: This study tests the hypothesis that the Radiation dose escalation to the macroscopic Tumor improves the locoregional control survival after concomitant chemoradiation over 2 years. As a transla...
Disease: Version SOC Term Classification Code Term Level
18.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10067821 Head and neck cancer PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Prematurely Ended)
Trial results: View results
EudraCT Number: 2020-002873-88 Sponsor Protocol Number: MGT-RPGR-021 Start Date:
Sponsor Name: MeiraGTx UK II Limited
Full Title: Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated with Variants in the RPGR gene
Medical condition: X-Linked Retinitis Pigmentosa caused by mutations in the RPGR gene
Disease: Version SOC Term Classification Code Term Level
20.0 10010331 - Congenital, familial and genetic disorders 10038914 Retinitis pigmentosa PT
Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: IE (Ongoing) NL (Ongoing) ES (Ongoing) DK (Ongoing)
Trial results: (No results available)
EudraCT Number: 2004-001223-37 Sponsor Protocol Number: 102038 Start Date:
Sponsor Name: GlaxoSmithKline S.A.
Full Title: Ensayo clínico abierto en fase IV, para evaluar la inmunogenicidad y reactogenicidad de la vacuna combinada DTPa (Infanrix) de GlaxoSmithKline Biologicals administrada como dosis de recuerdo a los ...
Medical condition: Inmunización primaria activa frente a la difteria, tétanos y tosferina en niños, a partir de los 2 meses de edad hasta los 7 años.
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: View results
EudraCT Number: 2005-003279-18 Sponsor Protocol Number: HLH-2004 Start Date:
Sponsor Name: Barncancerforskningsenheten, Astrid Lindgrens Barnsjukhus
Full Title: HLH-2004. Hemophagocytic Lymphohistiocytosis Study Group. Treatment Protocol of the Second International HLH Study 2004.
Medical condition: Hemophagocytic Lymphohistiocytosis (HLH), a life-threatening disease usually occurring in early childhood. HLH-2004 is an international treatment protocol which will be compared with the previous ...
Disease: Version SOC Term Classification Code Term Level
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: NO (Ongoing)
Trial results: (No results available)
EudraCT Number: 2014-000545-78 Sponsor Protocol Number: Rempex-505 Start Date:
Sponsor Name: Rempex Pharmaceuticals, Inc.
Full Title: A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF CARBAVANCE™ (MEROPENEM/RPX7009) COMPARED TO PIPERACILLIN/TAZOBACTAM IN TH...
Medical condition: complicated urinary tract infection (cUTI) or acute pyelonephritis (AP) with or without concurrent bacteremia
Disease: Version SOC Term Classification Code Term Level
18.0 10021881 - Infections and infestations 10037597 Pyelonephritis acute PT
18.0 10021881 - Infections and infestations 10046577 Urinary tract infections HLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) CZ (Completed) SK (Completed) IT (Completed) ES (Completed) PL (Completed) SI (Completed) BG (Completed) GR (Completed)
Trial results: View results
EudraCT Number: 2009-017228-24 Sponsor Protocol Number: CMM/DM1 Start Date:
Sponsor Name: Instituto Científico y Tecnológico de Navarra
Full Title: Ensayo clínico de tratamiento de la Diabetes Mellitus tipo 1 autoinmune con células madre mesenquimales autólogas
Medical condition: Diatetes mellitus tipo 1 autoinmune
Disease: Version SOC Term Classification Code Term Level
13 10045228 Diabetes mellitus tipo I LLT
Population Age: Adults Gender: Male, Female
Trial protocol: ES (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2010-023410-31 Sponsor Protocol Number: PLADSEL Start Date:
Sponsor Name: CHU DE POITIERS
Full Title: Simplification du test de sensibilité au sel : étude préalable chez l'enfant et l'adulte
Medical condition: Hypertension artérielle
Disease: Version SOC Term Classification Code Term Level
12.1 10020775 Hypertension arterial LLT
Population Age: Children, Under 18, Adults Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)
EudraCT Number: 2008-005571-10 Sponsor Protocol Number: 03-08-21-12 Start Date:
Sponsor Name: Kennedy Krieger Inst. Johns Hopkins Medicine
Full Title: DEXTROMETORPHAN IN RETT SYNDROME
Medical condition: Rett syndrome (RTT) is a neurological disorder with devastating consequences on the brain. It is characterized by stagnation of development followed by regression, both occurring between age 6 mont...
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Adolescents, Under 18 Gender: Female
Trial protocol: NO (Ongoing)
Trial results: (No results available)
EudraCT Number: 2018-003025-28 Sponsor Protocol Number: TUD-RELAX1-070 Start Date:
Sponsor Name: Technische Universität Dresden
Full Title: Phase-I/II trial for relapsed or refractory AML patients combining cytarabine and mitoxantrone with venetoclax
Medical condition: Patients 18-75 years with acute myeloid leukaemia (AML) at first or second relapse after intensive chemotherapy including allogeneic stem cell transplantation or primary refractory to standard indu...
Disease: Version SOC Term Classification Code Term Level
21.0 100000004864 10000886 Acute myeloid leukemia LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Ongoing)
Trial results: (No results available)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe